Peptides as receptor ligand drugs and their relationship to G-coupled signal transduction

Bibliography

• FREIDINGER RM: Toward peptide receptor ligand drugs: Progress on nonpeptides. Frog. Drug Res. (1993) 40:33–98.
   PubMedGoogle Scholar
• LATHAM PW: Therapeutic peptides revisited. Nat. Biotechnol. (1999) 17:755–757.
   PubMed Web of Science ®Google Scholar
• GIBBS JB: Mechanism-based target identification and drug discovery in cancer research. Science (2000) 287:1969–1973.
   PubMed Web of Science ®Google Scholar
• GASPARINI G, CALABRIA R, GION M: Molecular-targeted anticancer therapy: Challenges related to study design and choice of proper endpoints. Cancer j (2000) 6:117–131.
   PubMed Web of Science ®Google Scholar
• KREBS S, ROGVAN D: From peptides to peptidemimics: design of nonpeptide ligands for HLA proteins. Pharm. Acta Helvet. (1998) 73:173–181.
   PubMedGoogle Scholar
• ROBERTS B: Nuclear localization signal-mediated protein transport. Biochem. Biophys. Acta (1989) 1008:263–280.
   PubMed Web of Science ®Google Scholar
• WHITESIDE ST, GOODBLOWEN S: Signal transduction and nuclear targeting: regulation of transcription factor activity by subcellular localization. jScL (1993)104:949–955.
   Google Scholar
• BEHR TM, BEHE M, BECKER W: Diagnostic applications of radiolabeled peptides in nuclear endocrinology. Quart. j Nucl. Med. (1999) 43:268–280.
   PubMedGoogle Scholar
• SPADAU TW, KATZENELLENBOGEN JA: Protein & peptide labeling with tricarbamyl rubenium and technetium. Bioconjug. Chem. (1998) 9:765–772.
   PubMed Web of Science ®Google Scholar
• HIRAHARA K, SAITO S, SERIZAWA N: Oral administration of a dominant T-cell determinant peptide inhibits allergen TH1 and TH2 cell responses. j Allerg. Chia. Immurrol (1998) 102:961–967.
   PubMed Web of Science ®Google Scholar
• VAN ARNIER C, ASTORI M, KETTNER A: Allergen-derived long peptide immunotherapy down regulates IgE response and protects from anaphylaxis. Eur. Immurrol. (2000) 30:1638–1645.
   PubMed Web of Science ®Google Scholar
• GLINSKY VV, HUFLEYT ME, GLINSKY GV et al.: Effects of Thomsen-Freidenreich antigen-specific peptide p-30 beta-galactoside-mediated homotypic aggregation and adhesion to endothelium of human breast cancer. Cancer Res. (2000) 60:2584–2588.
   PubMed Web of Science ®Google Scholar
• MATSUOKA T, HIRAKAWA K, CHUNG YS et al: Adhesion polypeptides are useful for the prevention of peritoneal dissemination of gastric cancer. OM. Exp. Metast. (1998) 16:381–388.
   PubMed Web of Science ®Google Scholar
• SCHRAMM HJ, DEROSNY E, REBOUD-RAVAUX M etal.: Lipopeptides as dimerization inhibitors of HIV-1 protease. j Biol. Chem. (1999) 380:593–596.
   Google Scholar
• BIRCHALL JC, KELLAWAY IW, GUMBLETON M: Physical stability and in vitro gene expression efficiency of nebulised lipid-peptide-DNA complexes. IntL Pharmaceut. (2000) 197:221–231.
   PubMed Web of Science ®Google Scholar
• THURA SR, DIEDRICHS-MORING M, FRICKE H et al.: Oral tolerance with an HLA-peptide mimicking retinal antoantigen as a treatment of autoimmune uveitis. Immurrol. Lett. (1999) 68:205–212.
   PubMed Web of Science ®Google Scholar
• OGG GS, DUNBAR PR, CERUNDOLO V et al: Sensitization of tumor cells to lysis by virus-specific CTL using antibody-directed MHC Class 1/peptide complexes. Br .j Cancer (2000) 85:1058–1062.
   Google Scholar
• MAATO RI: Non-viral peptide-based approaches to gene delivery. j Dug Target. (1999) 7:249–268.
   PubMed Web of Science ®Google Scholar
• MORRIS MC, CHALOIN L, MERY J: A novel potent strategy for gene delivery using a single peptide vector as carrier. Nucleic Adds Res. (1999) 7:3510–3517.
   Google Scholar
• SAWA T, KURAHASHI K: Antimicrobiol peptides/proteins, application to the therapy of sepsis. Masui: jap. Anesthesiology (1999) 48:1186–1193.
   PubMedGoogle Scholar
• LAMB HM, WISEMAN LR: Pexigan acetate: a peptide with anti-bacterial activity. Drugs (1998) 56:1047–1052.
   PubMed Web of Science ®Google Scholar
• BISLAND SK, SINGH D, GARIEPY J: Potentiation of chlorine-6 photodynamic activity in vitro with peptide-based intracellular vehicles. Bioconjugate Chem. (1999) 10:982–992.
   PubMed Web of Science ®Google Scholar
• MORRIS MC, CHALOIN L, MERY J et al.: A novel potent strategy for gene delivery using a single peptide vector as a carrier. Nucl. Adds Res. (1999) 27:3510–3517.
   PubMed Web of Science ®Google Scholar
• MORRIS MC, VIDAL P, CHALOIN L et al.: A new peptide vector for efficient delivery of oligonucleotides into mammalian cells. Nucl. Add Res. (1997) 25:2730–2736.
   PubMed Web of Science ®Google Scholar
• GOA KL, NOBLES: A cyclic peptide for use in patients with acute coronary syndromes and undergoing percutaneous coronary intervention. Dugs (1999) 57:439–462.
   Google Scholar
• MAZUR W, KALUZA G, KLEIMAN NS: Antiplatelet therapy for treatment of acute coronary syndromes. Cardiol. OM. (1999) 17:345–357.
   Google Scholar
• NILSSON G, GUSTAFSSON M, VANDENBUSCHE G et al: Synthetic peptide-containing surfactants: evaluation of transmembrane versus amphipathic helices and surfactant protein-C poly-valyl-leucyl substitution. Eur. j Biochem. (1998) 255:116–124.
   PubMedGoogle Scholar
• MORIKAWA M, HIRATA Y, IMANAKA T: A study on the structure-function relationship of lipopeptide biosurfactants. Biochem. Biophys. Acta (2000) 1488:211–218.
   PubMed Web of Science ®Google Scholar
• GOLD DP, SHROEDER K, GOLDING A et al.: T-cell receptor peptides as immunotherapy for autoimmune disease. Crit. Rev. Immurrol (1997) 17:507–510.
   PubMed Web of Science ®Google Scholar
• BEHR TM, GOLDENBERG DM, BECKER W: Reducing the renal uptake of radiolabeled antibody: framents and peptides for diagnosis & therapy: present status, future projects and limitations. j Nucl. Med. (1998) 25:201–212.
   Web of Science ®Google Scholar
• XU LL, BENNETT G, STACKHOUSE KF et al: PSGR, a novel prostate-specific gene with homology to a G protein-coupled receptor, is over-expressed in prostate cancer. Cancer Res. (2000) 60:6568–6572.
   PubMed Web of Science ®Google Scholar
• BEHR TM, BEHE M, BECKER W: Diagnostic applications of radiolabeled peptides in nuclear endocrinology. Quart. j Nucl. Med. (1999) 43:268–280.
   PubMedGoogle Scholar
• BEHR TM, JENNER N, BEHE M et al: Radio-labeled peptides for targeting CCK-B/gastrin receptor-expressing tumors. j Nuc. Med. (1999) 40:1029–1044.
   PubMed Web of Science ®Google Scholar
• PODUSLO JF, CURRAN GL, KUMAR A et al.: Beta-sheet breaker peptide inhibitor of Alzheimer's amyloidogenesis with increased blood brain barrier permeability and resistance to proteolytic degradation. j Neurobiol. (1999) 39:371–382.
   PubMedGoogle Scholar
• DUTTA AS: Design and therapeutic potential of peptides. Adv. Drug Res. (1991) 21:145–165.
   Google Scholar
• MIZEJEWSKI GJ, DIAS JA, HAUER CR, HENRIKSON K1 GIERTHY J: Alpha-fetoprotein derived synthetic peptides: Assay of an estrogen-modifying regulatory segment. Mol. Cell Endocrinol. (1996) 118:15–23.
   PubMed Web of Science ®Google Scholar
• VAKHARIA D, MIZEJEWSKI GJ: Human alpha-fetoprotein peptides bind estrogen receptor and estradiol and suppress breast cancer. Breast Cancer Res. & Treat (2000) 63:41–52.
   PubMed Web of Science ®Google Scholar
• MESFIN FB, BENNETT JA, JACOBSON HI, ZHU S, ANDERSEN TT: Alpha-fetoprotein-derived anti-estrotrophic octapeptide. Biochim. Biophys. Cta (2000) 1501:33–43.
   PubMed Web of Science ®Google Scholar
• TORSHIN I: Direct and reversed amino acid sequence pattern analysis: structural reasons for activity of reversed sequence sites and results of kinase site mutagenesis. Biochem. J (2000) 345: 733–740.
   PubMed Web of Science ®Google Scholar
• SOYEZ D, TOULLEC JY, OLLIVAUX C et al.: L to D amino acid isomerization in a peptide hormone a late post-translational event occurring in neurosecretory cells. Biol. Chem. (2000) 275:37870–37875.
   Web of Science ®Google Scholar
• VEBER DF, FREIDINGER RIVI, PERLOW DS et al: A potent cyclic hexapeptide analogue of somatostatin. Nature (1981) 292:55–58.
   PubMed Web of Science ®Google Scholar
• RAHUEL J, RASETTI V, MAIBAUM J et al.: Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin. Chem. Biol. (2000) 7:493–504.
   PubMed Web of Science ®Google Scholar
• TAP PHARMACEUTICALS, INC: lupron'. Physician's Desk Reference. (1999):3136–3149.
   Google Scholar
• SAUSVILLE EA, JOHNSON JI: Molecules for the millennium: how will they look? New drug discovery year 2000. Br. J Cancer (2000) 83:1401–1404.
   PubMed Web of Science ®Google Scholar
• PILLAI 0, NAIR V, PODURI R: Transdermal iontophoresis. Pt. II. Peptide and Protein delivery. Meth. Find. Exptl. Gun. Pharmacal. (1999) 21:229–240.
   Google Scholar
• MERINO V, KALIA YN, GUY RH: Transdermal therapy and diagnosis by iontophoresis. Trends Biotechnol (1997) 15:288–290.
   PubMed Web of Science ®Google Scholar
• FRENHANI PB, BURINI RC: Mechanisms of absorption of amino acids and oligopeptides. Control and implications in human diet & therapy. Arch. Be Castroeneral. (1999) 36:227–237.
   Google Scholar
• ISHIDA H, SHIRAI T, MATSUDA Y et al: Emplics: An empirical approach for structure-based design of natural peptide drugs. J. Biochem. (2000) 128:561–574.
   PubMed Web of Science ®Google Scholar
• ROMANCZUK H, GALER CE, ZABNER J: Modification of an adenoviral vector with biologically selected peptides: a novel strategy for gene delivery to cells of choice. Hum. Gene Therap. (1999) 10:26215–26226.
   Google Scholar
• KING TR, FARRG Y, MAHON ES et al: Using a phage display library to identify basic residues in A-Raf required to mediate binding to the Src homology-2 domains in the p85 subunit of phosphatidylinositol 3'-kinase. J Biol. Chem. (2000) 275:36450–36453.
   PubMed Web of Science ®Google Scholar
• OBATA T, YAFFE MB, LEPARE GG et al: Peptide and protein library screening defines optimal substrate motifs for AKT/ PKB.J. BiaL Chem. (2000) 275:36108–36115.
   PubMed Web of Science ®Google Scholar
• FLECKENSTEIN B, JUNG G, WEISSMULLER KH: Quantitative analysis of peptide-MHC class-II interaction. Sem. Immutiol (1996) 11:405–416.
   Google Scholar
• PALMER SJ, REDFERN MR, SMITH GC et al: Sticky egyptians: a technique for assembling genes encoding constrained peptides of variable length. Nur. Acids Res. (1998) 26:2560–2564.
   PubMed Web of Science ®Google Scholar
• DUGUID JG, LI C, SHI M et al: A physico-chemical approach for predicting the effectiveness of peptide-gene delivery systems for use in plasmid-based gene therapy. Biophys J. (1998) 74:2802–2814.
   PubMed Web of Science ®Google Scholar
• KLEINERMAN ES: Biologic response modifiers: The next weapon against metastatic cancer. J NIH. Res. (1991) 3:47–50.
   Google Scholar
• MIZEJEWSKI GJ: Alpha-fetoprotein as a biologic response modifier: Relevance to Domain and subdomain structure. Proc. Soc. Exptl Biol. Med. (1997) 215:333–362.
   PubMed Web of Science ®Google Scholar
• SKOLNICK J, FETROW JS, KOLINSKI A: Structural genomics and its importance for gene function analysis. Nature Biotech. (2000) 18:283–287.
   PubMed Web of Science ®Google Scholar
• RAYMOND JR: Hereditary and acquired defects in signalling through the hormone receptor G-coupled complex. Am. J. Physiol (1994) 266:F163–F174.
   PubMed Web of Science ®Google Scholar
• LEFKOWITZ RJ: The superfamily of heptahelical receptors. Nature Cell Biol. (2000) 2:E133–E136.
   PubMed Web of Science ®Google Scholar
• KREDA SM, PICKLES RJ, LAZAROWSKI ER et al: G-protein-coupled receptors as targets for gene transfer vectors using natural small-molecule ligands. Nature Biotech. (2000) 18:635–640.
   PubMed Web of Science ®Google Scholar
• NGUYEN JT, PORTER M, AMOUI M et al: Improving 5H3 domain ligand selectivity using a non-natural scaffold. Chem. Biol. (2000) 7:463–473.
   PubMed Web of Science ®Google Scholar
• KERR JS, SLEE AM, MOUSA SA: Small molecule av integrin antagonists: novel anticancer agents. Exp. Opin Invest Drugs (2000) 9:1271–1279.
   PubMed Web of Science ®Google Scholar
• LARHAMMAR D, BLOMQUIST AG, WAHLESTEDT C: The receptor revolution - multiplicity of G-protein-coupled receptors. Drug Design Discovery (1993) 9:179–188.
   PubMedGoogle Scholar
• HAYFLECK JS: A family of heptahelical receptors with adhesion-like domains: A marriage between two superfamilies. Receptor Sig. Transduction Res. (2000) 20:119–131.
   PubMed Web of Science ®Google Scholar
• HORN F, VAN DER WENDEN EM, OLIVEIRA L et al.: Is there a signal behind the sequence? Proteins: Struct. Funct. Cen (2000) 41:448–459.
   PubMed Web of Science ®Google Scholar
• PALZEWSKI K, KUMASAKA T, HORT T et al: Crystal structure of Rhodopsin: A G- protein-coupled receptor. Science (2000) 289:739–744.
   PubMed Web of Science ®Google Scholar
• LYU RIVI, GERMANO PM, CHOI JK et al: Identification of an essential amino acid motif within the C terminus of the pituitary adenylate cyclase-activating polypeptide Type-I receptor that is critical for signal transduction but not for receptor internalization. J Biol. Chem. (2000) 275:36134–36142.
   PubMed Web of Science ®Google Scholar
• BONEMANN M, HOSEY M: G-protein coupled receptor kinases as modulators of G-protein signaling. J. Physiol. (1999) 517:5–23.
   PubMed Web of Science ®Google Scholar
• JELACIC TM, KENNEDY MF, WICKMAN K et al: Functional and biochemical evidence for G-protein-gated inwardly rectifying K+ (GIRK) channels composed of GIRK2 and GIRK3. J. Biol. Chem. (2000) 275:32211–32216.
   Google Scholar
• IACOVELLI L, SALLESE M, MARIGGIO S, DEBLASI A: Regulation of G-protein-coupled receptor kinase subtypes by calcium sensor proteins. FASEB J (1999) 13:1–8.
   PubMed Web of Science ®Google Scholar
• PEARSE BMF, SMITH CJ, OWEN DJ: Clathrin coat construction in endocytosis. Curl: Opin Struct. Biol. (2000) 10:220–228.
   PubMed Web of Science ®Google Scholar
• CERESA BP, SCHMID SL: Regulation of signal transduction by endocytosis. Curr. Opin Cell Biol. (2000) 12:204–210.
   PubMed Web of Science ®Google Scholar
• OAKLEY RH, LAPORTE SA, HOLT JA, BARAK S, CARON MG: Association of B-arrestin with G Protein-coupled receptors during clathrin-mediated endocytosis dictates the profile of receptor resensitization. J. Biol. Chem. (1999) 274:32248–32257.
   PubMed Web of Science ®Google Scholar
• TSAO PL, ZASTROW MV: Type-specific sorting of G-protein-coupled receptors after endocytosis. J. Biol. Chem. (2000) 275:11130–11140.
   PubMed Web of Science ®Google Scholar
• FREEDMAN NJ, LEFKOWITZ RJ: Desensitization of G-protein-coupled receptors. Rec. Prog. Hor. Res. (1996) 51:319–351.
   PubMedGoogle Scholar
• LOHSE MJ, ANDEXINGER S, PITCHER J et al.: Receptor-specific desensitization with purified proteins. Kinase dependence and receptor specificity of beta-arrestin in the adrenergic and rhodopsin systems. J. Biol. Chem. (1992) 267:8558–8564.
   Google Scholar
• KRUPNICK JG, GOODMAN OB, KEEN JH, BENOVIC JL: Arrestin/clathrin interaction localization of the clathrin binding domain of nonvisual arrestins to the carboxyl terminus. J. Biol. Chem. (1997) 272:15011–15016.
   PubMed Web of Science ®Google Scholar
• MCNIVEN MA, CAO H, PITTS KR, AND YOON Y: The dynamin family of mechanoenzymes: Pinching in new places. Trends Biol Sci (2000) 25:115–120.
   PubMed Web of Science ®Google Scholar
• HASBI A, POLASTION J, ALLOUCHE S et al: Desensitization of the opioid receptor correlates with its phosphorylation in SK-N-BE cells: Involvement of a G-protein-coupled receptor kinase. j Neuochem (1998) 70:2129–2138.
   PubMed Web of Science ®Google Scholar
• DRAKE MT, ZHU Y, KORNFELD S: The assembly of AP-3 adaptor complex-containing clathrin-coated vesicles on synthetic liposomes. Mol. Biol Cell (2000) 11:3723–3736.
   PubMed Web of Science ®Google Scholar
• OAKLEY RH, LAPORTE SA, HOLT JA: Association of B-arrestin with G-Protein-coupled receptors during clathrin-mediated endocytosis dictates the profile of receptor resensitization. j Biol Chem. (1999) 274:32248–32257.
   PubMed Web of Science ®Google Scholar
• SCHLEGEL A, LISANTI MP: A molecular dissection of caveolin-1 membrane attachment and oligomerization. I Biol Chem. (2000) 275:21605–21617.
   Web of Science ®Google Scholar
• MURTHY, KS, MAKHLOUF GM: Heterologous desensitization mediated by G-protein specific binding to caveolin. Biol Chem. (2000) 275:30211–30219.
   Web of Science ®Google Scholar
• PULVERMULLER A, SCHRODER K, FISCHER T et al: Interaction of meta-rhodopsin II. Arrestin peptides compete with arrestin and transducin. j Biol Chem. (2000) 275:37679–37685.
   Google Scholar
• ROMANI R, HOWES LG, MORRIS DL: Gastrin receptor antagonist CI-988 inhibits growth of human colon cancer in vivo and in vitro. Aust. NZ J. Surg. (1996) 66:235–237.
   PubMedGoogle Scholar
• DEVI LA: G-protein-coupled receptor dimmers in the lime light. TIPS (2000) 21:325–227.
   Google Scholar
• BRISCOE CE WAKELAM MJO: Heterologous desensitization of bombesin and vasopressin stimulated phospholipase D activity in Swiss 3T3 fibroblasts. FEBS Lett. (1995) 361:162–166.
   PubMed Web of Science ®Google Scholar
• ROCHEVILLE M, LANGE DC, KUMAR U et al.: Receptors for dopamine and somatostatin: Formation of hetero-oligomers with enhanced functional activity. Science (2000) 288:154–158.
   PubMed Web of Science ®Google Scholar
• HOLTBACK U, BRISMAR H, DIBONA GF et al.: Receptor recruitment: a mechanism for interactions between G-protein-coupled receptors. Proc. Natl. Acad. Sci. USA (1999) 96:7271–7275.
   PubMed Web of Science ®Google Scholar
• LEE KB, PTASIENSKI JA, PALS-RYLAARSDAM R et al: Arrestin binding to the M2 muscarinic acetylcholine receptor is precluded by an inhibitory element in the third intracellular loop of the receptor. _J. Biol. Chem. (2000) 275:9284–9289.
   PubMed Web of Science ®Google Scholar
• LEUTHAUSER K, GUJER R, ALDECOA A et al.: Receptor activity-modifying protein-1 forms heterodimers with two G-protein-coupled receptors to define ligand recognition. Biochem. J. (2000) 351:347–351.
   PubMed Web of Science ®Google Scholar
• SALAHPOUR A, ANGERS S, BOUVIER M: Functional significance of oligomerization of G-protein-coupled receptors. TEM(2000) 11:163–168.
   PubMed Web of Science ®Google Scholar
• VON GARNIER C, ASTORI A, KETTNER A et al.: Allergen-derived long peptide immunotheraphy down-regulates specific IgE response. Eur. j Immurrol. (2000) 30:1638–1645.
   PubMed Web of Science ®Google Scholar
• MCDONALD PH, CHOW CW, MILLER WE et al.: Beta-arrestin2: a receptor-regulated MAPK scaffold for the activation of JNK3. Science (2000) 290:1574–1577.
   PubMed Web of Science ®Google Scholar
• WILKINSON MG, MILLAR JB: Control of the eukaryotic cell cycle by MAP kinase signaling pathways. FASEB (2000) 14:2147–2157.
   PubMed Web of Science ®Google Scholar
• SAMUDRALA R, LEVITT M: Decoys `1R.' Us: A database of incorrect conformations to improve protein structure prediction. Protein Sci. (2000) 9:1399–1401.
   Google Scholar
• BROWDER T, FOLKMAN J, PIERIE-SHEPERD S: The hemostatic system as a regulator of angiogenesis: A review. _J. Biol. Chem. (2000) 275:1521–1524.
   PubMed Web of Science ®Google Scholar
• WEN W, MOSES MA, WIEDERSCHAIN D, ARBIZER JL, FOLKMAN J: The generation of endostatin is mediated by elastase. Cancer Res. (1999) 59:6052–6056.
   PubMed Web of Science ®Google Scholar
• CARROWAY RE, MITRA SP, COCHRANE DE: Structure of a biologically active neurotensin-related peptide obtained from pepsin-treated albumin. J. Biol. Chem. (1987) 262:5969–5973.
   Google Scholar
• BUTTERSTEIN GM, MIZEJEWSKI GJ: Alpha-fetoprotein inhibits frog metamorphosis: implications for protein motif conservation. Comp. Biochem. Physiol (1999) 124A:39–45.
   Google Scholar
• EISELE LE, MESFIN FB, BENNETT JA etal.: Studies on a growth-inhibitory peptide derived from alpha-fetoprotein and some analogs. I Peptide Res. (2001) 57:29–38.
   Google Scholar
• JARVINEN A: TRH-induced tachyphylaxis: present in the smooth muscle but not in the cardiorespiratory effects. Pharmacol Toxicol (1991) 68:371–374.
   PubMedGoogle Scholar
• JARVINEN A, PAAKKARI I, MANNESTO PT: Central and peripheral type benzodiazepine ligands displace TRH from its binding sites. Neuropeptides (1991) 19:147–149.
   PubMed Web of Science ®Google Scholar
• YAMADA M, SHIBUSAWA N, HASHIDA et al: Expression of thyrotropin-releasing hormone (TRH) receptor subtype-I in mouse pancreatic islets and HIT-T15, an insulin-secreting clonal beta cell line. Life Sci. (2000) 66:1119–1125.
   PubMed Web of Science ®Google Scholar
• BUCKLEY CD, PILLING D, HENRIQUEZ NV etal.: RGD peptides induce apoptosis by direct caspase-3 activation. Nature (1999) 397:534–539.
   Google Scholar
• MING Z, CHAO W, JIAN Y etal.: Synthesis of RGD-containing peptides and their vasodilation effect. Prep. Biochem. Biotechnol (2000) 30:247–256.
   Google Scholar
• SUEHIRO K, MIZUGUCHI J, NIHIYAMA K et al.: Fibrinogen binds to integrin a5l31 via the carboxyl-terminal RGD site of the a-chain. J. Biochem. (2000) 128:705–710.
   PubMed Web of Science ®Google Scholar
• LANZA TJ, DURRETTE PL, ROLLINS T et al.: Substituted 4,6 - diaminoquinolines as inhibitors of neutrophil C5 a receptor binding. I Med. Chem. (1992) 35:252–256.
   PubMed Web of Science ®Google Scholar
• LEVESQUE L, GAUDREAULT RC, MARCEAU F: Comparison of 2 classes of non-peptide drugs as antagonists of neutrophil receptors. Biochem. Pharmacol. (1992) 43:553–557.
   PubMedGoogle Scholar
• ZIMMERMAN DM, LEANDER JD: Selective opioid receptor agonists and antagonists: research tools and potential therapeutic agents. J. Med. Chem. (1990) 33:895–899.
   PubMed Web of Science ®Google Scholar
• PORTOGHESE PS: The role of concepts in structure: activity relationship studies of opioid ligands. J. Med. Chem. (1992) 35:1927–1931.
   PubMedGoogle Scholar
• ELSHOURBAGY NA, AMES RS, FITZGERALD LR et al.: Receptor for the pain modulatory neuropeptides FF and AF is an orphan G-protein-coupled receptor. Biol. Chem. (2000) 275:25965–25971.
   Web of Science ®Google Scholar
• ONDETTE MA, RUBIN B, CUSHMANN DW: Design of specific inhibitors of angiotensin-converting enzyme. Science (1977) 196:441–445.
   PubMed Web of Science ®Google Scholar
• PATCHETT AA, HARRIS E, TRISTRAM EW: A new class of angiotensin-converting enzyme inhibitors. Nature (1980) 288:280–283.
   PubMed Web of Science ®Google Scholar
• NOOR Z, BENARD 0, SEGER R: Activation of MAPK cascades by G-protein-coupled receptors: The case of gonadotrophin-releasing hormone receptor. TEM (2000) 11:91–99.
   PubMed Web of Science ®Google Scholar
• OGIER SA, MITCHELL R, FINK G: Solubilization of a large molecular weight form of the rat LHRH receptor. Endocrinol (1987) 115 151–159.
   Web of Science ®Google Scholar
• MELIN P, TROZNAR J, JOHANSSON B et al.: Synthetic antagonists of the myometrial response to vasopressin/ oxytocin. Endocrine/. (1986) 111:125–130.
   Google Scholar
• HAHN DW, DEMAREST KT, ERICSON R et al.: Evaluation of 1-deamino-D-Tyr-ethyl 2-THR-4-ORN-8, vasotocin antagonist. Am. j Obstet. Cyrrecol. (1987) 157:977–981.
   PubMedGoogle Scholar
• LARVE JA, DROZDA SE, SNIDER RIVI et al.: The discovery of cis-2-(diphenylethyl) 2-methoxyphenol-octan-3-amino antagonist. I Med. Chem. (1992) 35:2591–2592.
   PubMed Web of Science ®Google Scholar
• ROUISSI N, GITTER BD, WATERS DC et al.: Selectivity and specificity of a new nonpeptide quinuclidine antagonist of Substance - P. Biochem. Biophys. Res. Comm. (1991) 176:894–898.
   PubMed Web of Science ®Google Scholar
• BAUER W, BRINER U, DOEPFINER W et al: SM: 201-995, a very potent and selective octapeptide analog of somatostatin. Life Sci (1982) 31:1133–1136.
   PubMed Web of Science ®Google Scholar
• HUANG CM, WU YT, CHEN ST: Targeting delivery of paclitaxel into tumor cells via somatostatin receptor endocytosis. Chem. Biol. (2000) 7:453–461.
   PubMed Web of Science ®Google Scholar
• JENSEN RT, COY DH: Progress in the development of potent Bombasin receptor antagonists. Trends Pharm. Sri. (1991) 12:13–15.
   PubMed Web of Science ®Google Scholar
• BATTEY J, WADA E: Two district receptor subtypes for mammalian bombesin peptides. Trends Neuro. Li. (1991) 14:524–527.
   PubMed Web of Science ®Google Scholar
• DOHERTY AM: Endothelin: A new challenge. j Med. Chem. (1992) 35:1493–1495.
   PubMed Web of Science ®Google Scholar
• MASAKI T, YANAGISAWA M, GOTO K: Physiology and pharmacology of endothelins. Med. Res. Rev (1992) 12:391–394.
   PubMed Web of Science ®Google Scholar
• SANO T, MORISHITA Y, YAMADA K et al.: Effects of HS-142-1, a novel non-peptide ANP antagonist on diuresis and natriuresis induced by acute volume expansion in anesthetized rats. Biochem. Biophys. Res. Comm. (1992) 182:824–829.
   PubMed Web of Science ®Google Scholar
• TOKI S, MORISHITA Y, SANO T et al: H5142-1 a novel non-peptide ANP antagonist blocks cyclic GMP production. Net/rasa Lem (1992) 135:117–119.
   Google Scholar
• SANO T, MORISHITA Y, YAMADA K et al.: Effects of HS142-1, a novel non-peptide ANP antagonist, on diuresis and natriuresis. Biochem. Biophys. Res. Comm. (1992) 182:824–827.
   PubMed Web of Science ®Google Scholar
• OMURA S, TSUZUKI K, SANAZUKA T et al.: Acrolides with gastrointestinal motor stimulating activity. j Med. Chem. (1987) 30:1941–1944.
   PubMed Web of Science ®Google Scholar
• TSUZUKI K, SANAZUKA T, MARUI S et al.: Motilides macrolides with gastrointestinal motor stimulating activity. II Quaterary results. Chem. Pharm. Bull (1989) 37:2687–2689.
   PubMed Web of Science ®Google Scholar
• PERKIN SR, COSTENBADER CL, GARDNER JD: Actions of derivatives of cyclic nucleotides on dispersed acini from pancreas. J. Bio/ Chem. (1979) 254:5321–5328.
   PubMed Web of Science ®Google Scholar
• VIDAL Y, PLANA RR, CIFARELLI A et al.: Effects of antigastrin drugs on the interaction of 125I-gastrin with mucosa membranes. Hepato-Castroenterol. (1980) 27:41–45.
   Google Scholar
• MICHEL MC: Receptors for neuropeptide Y: multiple subtype and second messengers. Trend Pharm. Li. (1991) 12:389–391
   PubMed Web of Science ®Google Scholar
• EDVINSON L, ADAMSON M, JANSEN I: Neuropeptide-Y antagonistic properties of D-inosito1-1,2,6-triphosphate in guinea pigs. Neuropeptides (1990) 17:990105.
   Google Scholar
• LITVAK DA, ISEKI H, EVERS BM et al: Characterization of 2 novel proabsorptive peptide-Y analogs, BIM-43073D and BIM-4300C. Dig. Dis. Sri. (1999) 44:643–648.
   PubMed Web of Science ®Google Scholar
• TERUEL MN, MEYER T: Translocation and reversible localization of signaling proteins: A dynamic future for signal transduction. Cell (2000) 103:181–184.
   PubMed Web of Science ®Google Scholar
• GOODWIN DA, MEARES CF: Pretargeted peptide imaging and therapy. Can. Biotherap. Radiopharm. (1999) 14:145–152.
   PubMed Web of Science ®Google Scholar
• HONG FD, CLAYMAN GL: Isolation of a peptide for targeted drug delivery into human head and neck solid tumors. Cancer Res. (2000) 60:6551–6556.
   PubMed Web of Science ®Google Scholar
• HILLEGASS WB, NEWMAN AR, RACO DL: Economic issues in glycoprotein IIb/ Ma receptor therapy. Am. Heart j (1999) 138:524–532.
   Google Scholar
• HIRAHARA K, SAITO S, SERIZAWA N: Oral administration of a dominant T-cell determinant peptide inhibits allergen-specific TH1 and TH2 cell responses. Allerg. Clin. Immurrol (1998) 102:961–967.
   PubMed Web of Science ®Google Scholar
• BARANYI L, CAMPBELL W, OHSHIMA K: The antisense homology box: A new motif within proteins that encodes biologically active peptides. Nature Med. (2000) 1:894–901.
   Google Scholar
• FORD MG, PEARSE BMF, HIGGINS et al.: Simultaneous binding of PtdIns (4, 5) P2 and clathrin by AP180 in the nucleation of clathrin lattices on membranes. Science (2001) 291:1051–1055.
   PubMed Web of Science ®Google Scholar
• HARRISON-FINDIK D, MISRA S, JAIN SK et al: Dyramin inhibits posphatidlinositol 3-kinase in hematopoietic cells. Biochem. Biophy. Acta (2001) 1538:10–19.
   PubMed Web of Science ®Google Scholar
• KOHOUT TA, LIN FT, PERRY SJ et al: Beta-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking. Proc. Natl. Acad. Sci USA (2001) 98:1601–1606.
   PubMed Web of Science ®Google Scholar
• FINGERHUT A, FIGURA KV, HONING S; Binding of AP2 to sorting signals is modulated by API phosphorylation. I Biol. Chem. (2001) 5476–5482.
   Web of Science ®Google Scholar
• CHEVET E, CAMERON PH, PELLETIER MF et al: The endoplasmic reticulum: integration of protein folding, quality control, signaling and degradation. Cum: Opirr. Struct. Biol. (2001) 11:120–124.
   PubMed Web of Science ®Google Scholar
• SCHLEGEL A, LISANTI MP: Caveolae and their coat proteins, the caveolins: From election microscopy novelty to biological launching pad. J. Cell Physiol (2001) 186:329–337.
   PubMed Web of Science ®Google Scholar
• PALACIOS S, LALIOTI V etal.: Recycling of the insulin-sensitive glucose transporter GLUT4-access of surface internalized GLUT4 molecules to the perinuclear storage compartment is mediated by the Phe-Gln-Gln-Ile motif. j Biol. Chem. (2001) 276:3371–3383.
   Google Scholar